hcwbiologics.com (HCWB) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
HCW Biologics Inc. (HCWB) develops advanced treatments for inflammation and cancer, leveraging grants and investments in clinical trials. Scientific research focuses on protein synthesis for anti-aging therapy, as reflected in the stock quotes on this chart. Patent protection for geriatric medications ensures steady demand, and the EV/EBITDA metric stands at 0.00.
hcwbiologics.com - analytical breakdowns and key metrics (HCWB)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
Debt to Equity HCW Biologics Inc.|HCWB - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital HCW Biologics|HCWB - Company Cumulative Debt|Debts to Book Capitalization HCW Biologics|HCWB - Company Long-Term Loans and Borrowings|Company Short-Term Debts HCW Biologics|Quick Liquidity Indicator hcwbiologics.com
- business earnings and investment ratios data:
HCWB - Net Income|Future Profit HCW Biologics Inc.|HCWB - Company Value to Net Income|Forward P/E Multiple HCW Biologics|HCWB - Price/Earnings to Growth Ratio|EV/EBITDA Multiple HCW Biologics|HCWB - Operating income before deduction of amortization|Earnings per share for the last twelve months HCW Biologics|HCWB - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months hcwbiologics.com|HCWB - Earnings per share growth in current year|Net earnings per share growth forecast for next year HCW Biologics Inc.
Initial company analysis:HCW Biologics Inc HCWB
HCW Biologics Inc. (HCWB) operates in a capital-intensive R&D mode, where future scalability depends on transferring molecules to partners. This ratio compares the total enterprise value, including debt, to its operating profit, revealing the efficiency of cash flow generation. A sharp increase in the business valuation level via EV/EBITDA signals to the investor not an overvaluation, but a critical drop in operating income.
Key competitors
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|Vera Pharma - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation DNTH (Dianthus Corp)|PHVS: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio AbCellera|Enterprise Value to EBITDA Ratio TRML|Enterprise Value to EBITDA Ratio Precigen Inc (PGEN)|Enterprise Value to EBITDA Ratio PHAR (Pharming)|NKTR (Nektar Corp) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple UPB (Upstream Bio Inc)|zenasbio.com - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Immunome - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Gossamer Bio Inc GOSS|KalVista Pharmaceuticals Inc (KALV) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Septerna Pharma (SEPN)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pieris Pharmaceuticals|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SVRA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Rigel Pharmaceuticals, Inc. (RIGL)|ANAB - Company Value to EBITDA|EV/EBITDA Multiple ATXS (Astria Pharma)|Enterprise Value to EBITDA Multiple enGene Corp|RAPT Therapeutics - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Aerovate Therapeutics Inc JBIO|ACRS: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Kyverna Therapeutics Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tiziana Life Sciences PLC|Cabaletta Bio Inc (CABA) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio VTYX (Ventyx Biosciences)|THTX (theratech.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple AVTX (Avalo Therapeutics)|Total Company Value to Operating Income Before Depreciation Ratio Eledon Pharmaceuticals Inc. (ELDN)|AGEN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CLYM (Climb Bio, Inc) - Enterprise Value to Operating Income Before Depreciation|ZURA: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio atyrpharma.com|Enterprise Value to EBITDA Ratio ADAG|Ikena Oncology, Inc. (IMA) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple STTK|EQ (equilliumbio.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple CNTB (Connect Biopharma Holdings Limited)|IMUX - Enterprise Value to EBITDA Ratio|ATRA: Enterprise Value to EBITDA Ratio|InflaRx N.V. (IFRX) - Enterprise Value to EBITDA Ratio|XFOR: EV/EBITDA Multiple|ACET (Adicet Bio, Inc.) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Celularity Inc|inmunebio.com - Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple BRNS|KZR (Kezar Life Sciences Inc.) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple SABS (SAB Biotherapeutics, Inc)|EV/EBITDA Multiple Akari Therapeutics, Plc AKTX|ENLV - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation QTTB (Q32 Bio Inc.)|GeoVax (GOVX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Edesa Biotech Inc|IBIO (iBio Corp) - EV/EBITDA Multiple|EV/EBITDA Multiple Carisma Tx|Enterprise Value to EBITDA Ratio XTLB (XTL Biopharmaceuticals)|BOLT (boltbio.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple APVO (Aptevo Therapeutics Inc.)|Total Company Value to Operating Income Before Depreciation Ratio aimimmuno.com (AIM)|ADTX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GRI Bio Corporation (GRI) - Enterprise Value to EBITDA Ratio|XORTX Therapeutics Inc. (XRTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio reshapelifesciences.com|Enterprise Value to EBITDA Ratio REVB|EV/EBITDA Multiple Indaptus Therapeutics Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Scinai (SCNI)|calcimedica.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AFMD (Affimed N.V.)|Allakos Inc (ALLK) - Company Value to EBITDA|HOOKIPA - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation IGMS (IGM Biosciences, Inc.)|ITOS: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Ocean Biomedical Corp|Enterprise Value to EBITDA Ratio TCBP|Enterprise Value to EBITDA Ratio thirdharmonicbio.com (THRD)
